ACHC Acadia Healthcare Company Inc.

Acadia Healthcare Names R. David Kelly to Board of Directors

Acadia Healthcare Company, Inc. (NASDAQ: ACHC) today announced that R. David Kelly has been appointed to serve as an independent director on the Company’s Board of Directors.

This press release features multimedia. View the full release here:

Acadia Healthcare Names R. David Kelly To Board of Directors (Photo: Business Wire)

Acadia Healthcare Names R. David Kelly To Board of Directors (Photo: Business Wire)

Kelly brings over 35 years of investment experience to Acadia, having served public companies and private partnerships in the financial advisory and real estate development sectors. He is the founder and managing partner of StraightLine Realty Partners, an alternative investment platform based in Dallas, Texas, with real estate, financial services and venture capital holdings. Prior to founding StraightLine Realty Partners, he was founder and partner of Carleton Residential Properties, where he created one of the largest residential developers and general contractors in the Southwest. He previously held investment positions with Trammell Crow Company, Goldman Sachs & Co., and Salomon Brothers.

From 2007 to 2017, Kelly served as a trustee and chairman of the $197B Teacher’s Retirement System of Texas. From 2001 to 2006, he was a gubernatorial appointee to the Texas Public Finance Authority and served as chairman from 2002 to 2006.

Kelly also serves as founder, chairman and chief executive officer of Croesus and Company, managing director and co-founder of Serra Real Estate Capital, LLC, lead director of TCW Direct Lending, lead director of Invesco’s INREIT real estate platform and at-large director of Ashton Woods Homes.

Kelly actively contributes to organizations that support education and children’s health. He serves Children’s Health, the leading pediatric health care system in North Texas, as director of the Children’s Medical Center Plano Governing Board and member of the Children’s Health Investment and Finance committees. He also serves on the Advisory Board of Sponsors for Educational Opportunity.

Kelly graduated as a John Harvard Scholar in Economics from Harvard University and completed a Master of Business Administration at Stanford University Graduate School of Business.

“We are delighted to welcome David Kelly to our Board of Directors as an independent director,” said Reeve B. Waud, Chairman of the Board of Acadia Healthcare. “His extensive experience in financial advisory and real estate development will be invaluable as we continue to extend our market reach through strategic investments in both current and new facilities across the country. His impressive history in government service and philanthropic support of children’s health and education programs aligns well with our corporate culture. We are confident he will make a meaningful contribution to the work of the Acadia Board of Directors, and we look forward to his insight as we continue to execute our growth strategy.”

“It is a privilege and honor to join the Acadia Board of Directors,” added Kelly. “Acadia plays an important role in addressing the critical societal need for behavioral healthcare services. I look forward to working with the leadership team and other board members as we advance Acadia’s mission.”

About Acadia Healthcare Company, Inc.

Acadia is a leading provider of behavioral healthcare services across the United States. As of March 31, 2022, Acadia operated a network of 238 behavioral healthcare facilities with approximately 10,600 beds in 40 states and Puerto Rico. With more than 22,500 employees serving approximately 70,000 patients daily, Acadia is the largest stand-alone behavioral health company in the U.S. Acadia provides behavioral healthcare services to its patients in a variety of settings, including inpatient psychiatric hospitals, specialty treatment facilities, residential treatment centers and outpatient clinics.

EN
28/06/2022

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Acadia Healthcare Company Inc.

 PRESS RELEASE

Acadia Healthcare Announces Pricing of $550 Million Senior Notes Due 2...

FRANKLIN, Tenn.--(BUSINESS WIRE)-- Acadia Healthcare Company, Inc. (NASDAQ: ACHC) (the “Company” or “Acadia”) announced today the pricing of its private offering (the “Offering”) of $550 million in aggregate principal amount of 7.375% senior notes due 2033 (the “Notes”), which represents an increase of $50 million in aggregate principal amount from its previous announcement. The Offering is expected to close on March 10, 2025. The closing of the Offering is subject to the satisfaction of customary closing and market conditions. The Company intends to use the proceeds from the Offering to prep...

Moody's Ratings assigns a Ba3 to Acadia's new senior unsecured notes

Moody's Ratings (Moody's) assigned a Ba3 rating to Acadia Healthcare Company, Inc.'s ("Acadia") proposed $500 million senior unsecured notes. There are no changes to the company's existing Ba2 Corporate Family Rating (CFR), Ba2-PD Probability of Default Rating, and Ba3 senior unsecured ratings. The ...

 PRESS RELEASE

Acadia Healthcare Announces Launch of $500 Million Senior Notes Offeri...

FRANKLIN, Tenn.--(BUSINESS WIRE)-- Acadia Healthcare Company, Inc. (NASDAQ: ACHC) (the “Company” or “Acadia”) announced today that it has launched a private offering (the “Offering”) of $500 million in aggregate principal amount of senior notes due 2033 (the “Notes”), subject to market conditions and other considerations. The Company intends to use the proceeds from the Offering to prepay a portion of the outstanding borrowings under its existing senior secured revolving line of credit. The Notes have not been registered under the Securities Act of 1933, as amended (the “Securities Act”), an...

Moody's Ratings announces completion of a periodic review of ratings o...

Moody's Ratings (Moody's) has completed a periodic review of the ratings of Acadia Healthcare Company, Inc. and other ratings that are associated with this issuer. The review was conducted through a rating committee held on 26 February 2025 in which we reassessed the appropriateness of the ratings ...

 PRESS RELEASE

Acadia Healthcare Reports Fourth Quarter 2024 Results

FRANKLIN, Tenn.--(BUSINESS WIRE)-- Acadia Healthcare Company, Inc. (“Acadia” or the “Company”) (NASDAQ: ACHC) today announced financial results for the fourth quarter and year ended December 31, 2024. Fourth Quarter 2024 Highlights Revenue totaled $774.2 million, an increase of 4.2% over the fourth quarter of 2023. Same facility revenue increased 4.7% compared with the fourth quarter of 2023, including an increase in patient days of 3.2% and an increase in revenue per patient day of 1.4%. Net income attributable to Acadia totaled $32.6 million, or $0.35 per diluted share. Adjuste...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch